Where does Therapeutic Proteins International, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Therapeutic Proteins International, LLC ranks #17,276 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Therapeutic Proteins International, LLC hold?

Therapeutic Proteins International, LLC holds 17 US utility patents granted between 2015 and 2017, spanning 14 technology areas.

What is Therapeutic Proteins International, LLC's Innovation Score?

Therapeutic Proteins International, LLC has an Innovation Score of 30.1 out of 100 (33rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Therapeutic Proteins International, LLC's patent grant rate increasing or decreasing?

Therapeutic Proteins International, LLC's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Therapeutic Proteins International, LLC's patents?

Therapeutic Proteins International, LLC's patents average 11.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Therapeutic Proteins International, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Therapeutic Proteins International, LLC

Q: What technology areas does Therapeutic Proteins International, LLC focus on?

Therapeutic Proteins International, LLC's top technology area is C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters) with 16 patents, ranking #39 of 832 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

USPTO PatentsView assignee record - 17 granted patents across 14 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Therapeutic ranks #17,276 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 14 technology areas.

#17,276
of 49,997 US assignees by volume: 33rd percentile
by Innovation Score (30.1/100): 11.5
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17276 · US Corporation #17,276 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #17,276/49,997
PHOTO-FINISH Texmag Vertriebsgese…
CPC-FOCUS C12M · 14 areas
INNOV-THIN 30.1/100
CLAIMS-PAR 11.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Texmag GmbH Vertriebsgesellschaft (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Therapeutic’s 30.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (33%) Velocity 0.0 pts (0%) Breadth 13.2 pts (44%) Claim depth 6.9 pts (23%)

Qualcomm Incorporated · highest

85
Therapeutic… · this assignee

30
3D Lighting… · lowest

7

What this shows Therapeutic's Innovation Score is 30.1/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Therapeutic?

Each dot is one of Therapeutic’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Therapeutic’s own 11.5 claims/patent is at or below the 13.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Therapeutic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Therapeutic's grants concentrate

Therapeutic Proteins International, LLC is a focused PatentsView assignee: 14 CPC subclasses with 94.1% of grants classified under C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme). Peak complete grant year is 2016 (11 grants) versus a trough of 1 in 2017. By volume, Therapeutic sits between Texmag GmbH Vertriebsgesellschaft and Tosjami B. V..

Texmag Vertriebsg…

17
The Burchell Nurs…

17
The Shyft Group

17
The Topline

17
Tidal Systems

17
Tile Redi

17
Tomtom North Amer…

17
Tosjami B V

17
Therapeutic Prote… ◀

17

What this shows Therapeutic holds 17 patents at rank #17,285, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Therapeutic

By rank, the assignees closest to #17,285 in granted patent volume.

Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)

Other assignees with the most granted patents in Therapeutic's primary technology class.

Therapeutic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Therapeutic Proteins International, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	29.4%
2016	11	64.7%
2017	1	5.9%

Which technologies does Therapeutic Proteins International, LLC patent most?

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 16

C07K - Peptides 9

B01D - Separation 7

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 4

Y10T - Technical Subjects Covered BY Former US Classification 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

F24F - AIR-CONDITIONING; AIR-HUMIDIFICATION; VENTILATION; USE OF AIR Currents FOR Screening 2

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Y02C - Capture, Storage, Sequestration OR Disposal OF Greenhouse Gases [GHG] 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Therapeutic Proteins International, LLC's patent record in context - here's where to go next.

Therapeutic Proteins International, LLC's lead technology class is C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme), 94.1% of its portfolio - see every assignee active in that class. Explore C12M
Ranked #17,276 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Therapeutic Proteins International, LLC against Texmag GmbH Vertriebsgesellschaft, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.